Asana Biosciences (United States)
- Research works
- 26 ▲ 28% vs 2013–17
- Citations
- 410 15.6 per fractional work
- Top-10% rate
- 19.8% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Asana Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 27.6×. Every wedge is a field page.
Which keywords describe research at Asana Biosciences (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Immune Response, Medicinal Chemistry, Glycosylation, Cancer Therapy, Oncogenic Mutations, BRAF gene and MAP Kinase.
- PET Imaging
- Trastuzumab
- HER2
- Monoclonal Antibody
- Heterocyclic Compounds
- Breast Cancer
- Pharmacokinetics
- Therapeutic Antibodies
- Chemotherapy
- MAP Kinase
- Oncogenic Mutations
- Glycosylation
- Targeted Therapy
- Immune Response
- Medicinal Chemistry
- Cancer Therapy
- BRAF gene
- Cell-Free DNA
- Fc Receptors
- Inflammation
- Cancer
- Anticancer Agents
- Cancer Genomics
- Mutational Signatures
- Molecular Docking
- Virtual Screening
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Immune Response3▲ 18×2 topics
- Targeted Therapy3▲ 51×4 topics
- Medicinal Chemistry3▲ 28×3 topics
- Glycosylation2▲ 38×3 topics
- Cancer Therapy2▲ 13×2 topics
- Oncogenic Mutations2▲ 179×2 topics
- BRAF gene2▲ 435×1 topic
- MAP Kinase2▲ 435×1 topic
- Cell-Free DNA2▲ 80×2 topics
- Chemotherapy2▲ 10×7 topics
- Fc Receptors2▲ 70×1 topic
- Therapeutic Antibodies2▲ 54×1 topic
- Inflammation2▲ 2.8×4 topics
- Pharmacokinetics2▲ 24×2 topics
- Cancer2▲ 4.3×5 topics
- Breast Cancer2▲ 21×3 topics
- Anticancer Agents1▲ 21×1 topic
- Heterocyclic Compounds1▲ 34×1 topic
- Cancer Genomics1▲ 92×1 topic
- Monoclonal Antibody1▲ 70×2 topics
- Mutational Signatures1▲ 92×1 topic
- HER21▲ 156×1 topic
- Molecular Docking1▲ 33×1 topic
- Trastuzumab1▲ 110×1 topic
- Virtual Screening1▲ 67×1 topic
- PET Imaging1▲ 19×2 topics
Which research topics does Asana Biosciences (United States) publish most on?
By volume in 2022–2025: Pharmacogenetics and Drug Metabolism, BRCA gene mutations in cancer, Genomics and Rare Diseases and Metabolomics and Mass Spectrometry Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 2 BRCA gene mutations in cancer Genetics 0 works
- 3 Genomics and Rare Diseases Genetics 0 works
- 4 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
- 5 Mass Spectrometry Techniques and Applications Spectroscopy 0 works
- 6 Advanced Proteomics Techniques and Applications Spectroscopy 0 works
- 7 Cancer Genomics and Diagnostics Cancer Research 0 works
- 8 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 9 Cancer therapeutics and mechanisms Molecular Biology 0 works
- 10 Periodontal Regeneration and Treatments Urology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Asana Biosciences (United States)'s research output changed?
Output in 2018–2022 was 28% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lawrenceville
- Rider University
- Notre Dame High School
- Xybion Corporation (United States)
- Greenhouse Gas Industries (United States)
- Celsion (United States)
- Generation Biotech (United States)
- Princeton Power Systems (United states)
- Adare Pharma Solutions (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.